Although weight loss is a common consideration for patients initiating treatment with glucagon-like peptide (GLP)-1 receptor agonists, managing these treatments involves many considerations, including glycemic control and nutrition, among others. In an interview with Pharmacy Times, experts…
[ad_2]
Source link
